PG19 Heart-lung interaction

Postgraduate Course
Chairs: L. Lahousse (Ghent, Belgium), L. Fabbri (Modena, Italy)
Aims: Access educational materials here
to describe the diagnosis and treatment of heart failure and coronary artery disease; to delineate how lung disease hinders the diagnostic process, including physical examination, biomarkers, chest X ray and echocardiography; to discuss the duration of treatment following unprovoked pulmonary embolism, the need to pause anticoagulation before invasive procedures, and the management of bleeding given that new oral anticoagulation has changed, improved and complicated the treatment of acute and chronic pulmonary embolism.

Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation? I. Stone (London, United Kingdom)
Heart failure and coronary artery disease in lung disease S. Andreas (Immenhausen, Germany)
Group assignment I. Stone (London, United Kingdom), S. Andreas (Immenhausen, Germany)
Diagnosing pulmonary embolism in lung disease H. Olschewski (Graz, Austria)
Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation M. Lankeit (Mainz, Germany)